{"disease":{"id":"zika-virus-infection","name":"zika virus infection"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07358910","title":"Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Institut Pasteur du Cambodge","has_results":false},{"nct_id":"NCT03055585","title":"Applying Wolbachia to Eliminate Dengue","phase":"NA","overall_status":"TERMINATED","enrollment_count":8173,"lead_sponsor_name":"Gadjah Mada University","has_results":false},{"nct_id":"NCT07520279","title":"Xpert® Tropical Fever Test on GeneXpert® Edge X System","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":2500,"lead_sponsor_name":"Cepheid","has_results":false},{"nct_id":"NCT03110770","title":"VRC 705: A Zika Virus DNA Vaccine in Healthy Adults and Adolescents","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":2428,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":true},{"nct_id":"NCT03631719","title":"Impact of Wolbachia Deployment on Arboviral Disease Incidence in Medellin and Bello, Colombia","phase":"","overall_status":"COMPLETED","enrollment_count":834,"lead_sponsor_name":"Universidad de Antioquia","has_results":false},{"nct_id":"NCT03776903","title":"Evaluation of the Clinical Performance of the ZIKV Detect™ 2.0 IgM Capture ELISA","phase":"","overall_status":"COMPLETED","enrollment_count":600,"lead_sponsor_name":"InBios International, Inc.","has_results":false},{"nct_id":"NCT03206541","title":"Neurologic Manifestations of the Arbovirus Infection in Colombia","phase":"","overall_status":"COMPLETED","enrollment_count":570,"lead_sponsor_name":"Johns Hopkins University","has_results":false},{"nct_id":"NCT03255369","title":"Vertical Exposure to Zika Virus and Its Consequences for Child Neurodevelopment (ZIKVIRUSIFF)","phase":"","overall_status":"UNKNOWN","enrollment_count":500,"lead_sponsor_name":"Oswaldo Cruz Foundation","has_results":false},{"nct_id":"NCT03161444","title":"Estimated Cumulative Incidence of Zika Infection at the End of the First Epidemic in the French West Indies in a Sample of Patients Followed for HIV Infection.","phase":"NA","overall_status":"TERMINATED","enrollment_count":354,"lead_sponsor_name":"University Hospital Center of Martinique","has_results":false},{"nct_id":"NCT03343626","title":"Safety, Immunogenicity, and Dose Ranging Study of Inactivated Zika Virus Vaccine in Healthy Participants","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":271,"lead_sponsor_name":"Takeda","has_results":true},{"nct_id":"NCT04398901","title":"Neurodevelopmental Outcomes in ZIKV-Exposed Children","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":204,"lead_sponsor_name":"Children's National Research Institute","has_results":false},{"nct_id":"NCT06859619","title":"Serological Measurement of Montpellier Professionals' Contacts with Infectious Agents Responsible for Animal-borne Diseases","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":183,"lead_sponsor_name":"University Hospital, Montpellier","has_results":false},{"nct_id":"NCT06334393","title":"Phase 1 Trial to Assess the Safety and Immunogenicity of an Inactivated, Adjuvanted Whole Zika Virus Vaccine Candidate (VLA1601) in Healthy Adults","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":150,"lead_sponsor_name":"Valneva Austria GmbH","has_results":false},{"nct_id":"NCT04697147","title":"Zika and Neurodevelopment Among Infants in Grenada","phase":"NA","overall_status":"COMPLETED","enrollment_count":148,"lead_sponsor_name":"Windward Islands Research and Education Foundation","has_results":false},{"nct_id":"NCT03008122","title":"Phase I, Randomized, Double-blinded, Placebo-Controlled Dose De-escalation Study to Evaluate Safety and Immunogenicity of Alum Adjuvanted Zika Virus Purified Inactivated Vaccine (ZPIV) in Adults in a Flavivirus Endemic Area","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":91,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":true},{"nct_id":"NCT02952833","title":"ZIKA Vaccine in Naive Subjects","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":91,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":false},{"nct_id":"NCT02963909","title":"A Phase 1, First-in-human, Double-blinded, Randomized, Placebo-controlled Trial of a Zika Virus Purified Inactivated Vaccine (ZPIV) With Alum Adjuvant in Healthy Flavivirus-naive and Flavivirus-Primed Subjects.","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":75,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":false},{"nct_id":"NCT03425149","title":"Randomized, Placebo-controlled, Observer-blinded Phase 1 Safety and Immunogenicity Study of Inactivated Zika Virus Vaccine Candidate in Healthy Adults","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":67,"lead_sponsor_name":"Valneva Austria GmbH","has_results":false},{"nct_id":"NCT05041439","title":"Adherence to Care for Children With Congenital Zika Virus Infection in Puerto Rico","phase":"NA","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"Massachusetts General Hospital","has_results":true},{"nct_id":"NCT04033068","title":"Safety and Immunogenicity of a Novel Vaccine Formulation MV-ZIKA-RSP (V187-001)","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":48,"lead_sponsor_name":"Themis Bioscience GmbH","has_results":true},{"nct_id":"NCT04478656","title":"Safety and Immunogenicity of BBV121","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":48,"lead_sponsor_name":"Bharat Biotech International Limited","has_results":false},{"nct_id":"NCT02794181","title":"Zika Virus and Related Arbovirus Infections in Deferred Blood Donors (ZVADD)","phase":"","overall_status":"COMPLETED","enrollment_count":34,"lead_sponsor_name":"National Institutes of Health Clinical Center (CC)","has_results":false},{"nct_id":"NCT03679728","title":"Sensorimotor Outcomes of Children Exposed to Foetal Zika Virus Infection","phase":"","overall_status":"COMPLETED","enrollment_count":31,"lead_sponsor_name":"University of Sao Paulo","has_results":false},{"nct_id":"NCT03624946","title":"Study in Healthy Volunteers Evaluating Safety and Pharmacokinetics of Zika Virus Immune Globulin (ZIKV-IG)","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":30,"lead_sponsor_name":"Emergent BioSolutions","has_results":true},{"nct_id":"NCT03443830","title":"Safety and Tolerability of an Antibody Against Zika Virus (Tyzivumab) in Humans","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":24,"lead_sponsor_name":"Tychan Pte Ltd.","has_results":false},{"nct_id":"NCT03330600","title":"Efficacy of Aquatic Physiotherapy in Children With Microcephaly by Zika Virus Congenital Syndrome","phase":"NA","overall_status":"COMPLETED","enrollment_count":12,"lead_sponsor_name":"Universidade Federal de Pernambuco","has_results":false},{"nct_id":"NCT05589012","title":"Evaluation of Viral Replication by Tonate Virus (TONV) and Zika Virus (ZIKV), Within an ex Vivo Trophoblast and Placental Model","phase":"","overall_status":"UNKNOWN","enrollment_count":8,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT03776695","title":"Safety and Tolerability of an Antibody Against Zika Virus (Tyzivumab) in ZIKV Infected Patients","phase":"PHASE1","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Tychan Pte Ltd.","has_results":false},{"nct_id":"NCT03204409","title":"ZIKAlliance Natural History Study","phase":"","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"University of Heidelberg Medical Center","has_results":false}],"total":29},"guidelines":[],"source":"Drug Landscape verified database"}